No Data
No Data
H.C. Wainwright Downgrades CervoMed(CRVO.US) to Hold Rating
HC Wainwright & Co. Downgrades CervoMed to Neutral
Express News | CervoMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
CervoMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Canaccord Genuity Maintains Buy on CervoMed, Lowers Price Target to $12
Roth MKM Maintains CervoMed(CRVO.US) With Buy Rating, Cuts Target Price to $4